{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluids&page=16", "query": { "intervention": "Fluids", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 3553, "total_pages": 356, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluids&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluids&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T14:57:25.519Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02369835", "title": "Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Head and Neck Carcinoma", "Radiation-Induced Dermatitis" ], "interventions": [ { "name": "Dakin's solution", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2015-05", "completion_date": "2018-07-18", "has_results": true, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 2, "location_summary": "San Jose, California • Stanford, California", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02369835" }, { "nct_id": "NCT00352976", "title": "TBI Dose De-escalation for Fanconi Anemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Fanconi Anemia" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Total Body Irradiation", "type": "PROCEDURE" }, { "name": "Bone Marrow Transplantation", "type": "PROCEDURE" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 83, "start_date": "2006-05-18", "completion_date": "2020-10-09", "has_results": true, "last_update_posted_date": "2021-11-24", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00352976" }, { "nct_id": "NCT04338776", "title": "Comparing UroLift Experience Against Rezūm", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Benign Prostatic Hyperplasia" ], "interventions": [ { "name": "UroLift", "type": "DEVICE" }, { "name": "Rezum", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NeoTract, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "MALE", "summary": "50 Years and older · Male only" }, "enrollment_count": 120, "start_date": "2021-01-22", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 7, "location_summary": "Los Angeles, California • Royal Oak, Michigan • Garden City, New York + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "Garden City", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04338776" }, { "nct_id": "NCT04565015", "title": "Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Primary Immune Deficiency" ], "interventions": [ { "name": "GC5107", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GC Biopharma Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "2 Years to 16 Years" }, "enrollment_count": 24, "start_date": "2020-12-21", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2025-07-25", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 5, "location_summary": "Aurora, Colorado • Centennial, Colorado • Dallas, Texas + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Dallas", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04565015" }, { "nct_id": "NCT04512235", "title": "A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "AL Amyloidosis" ], "interventions": [ { "name": "CAEL-101", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 281, "start_date": "2020-11-03", "completion_date": "2027-04-08", "has_results": true, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 32, "location_summary": "Scottsdale, Arizona • Duarte, California • Palo Alto, California + 26 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04512235" }, { "nct_id": "NCT01673217", "title": "Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Fallopian Tube Cancer", "Recurrent Ovarian Epithelial Cancer", "Recurrent Primary Peritoneal Cavity Cancer" ], "interventions": [ { "name": "decitabine", "type": "DRUG" }, { "name": "NY-ESO-1 peptide vaccine", "type": "BIOLOGICAL" }, { "name": "pegylated liposomal doxorubicin hydrochloride", "type": "DRUG" }, { "name": "sargramostim", "type": "BIOLOGICAL" }, { "name": "incomplete Freund's adjuvant", "type": "BIOLOGICAL" }, { "name": "immunohistochemistry staining method", "type": "OTHER" }, { "name": "liquid chromatography", "type": "OTHER" }, { "name": "mass spectrometry", "type": "OTHER" }, { "name": "reverse transcriptase-polymerase chain reaction", "type": "GENETIC" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "DNA methylation analysis", "type": "GENETIC" }, { "name": "enzyme-linked immunosorbent assay", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER", "GENETIC" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 18, "start_date": "2009-04", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2022-08-01", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01673217" }, { "nct_id": "NCT00886236", "title": "Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity, Morbid", "Postoperative Pain", "Postoperative Nausea and Vomiting" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 62, "start_date": "2008-02", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2018-09-20", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00886236" }, { "nct_id": "NCT03497234", "title": "Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intra-Amniotic Infection of Foetus" ], "interventions": [ { "name": "Perilynx Analyzer to measure AF and VF fluid", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Hologic, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 0, "start_date": "2018-03-28", "completion_date": "2020-03-31", "has_results": false, "last_update_posted_date": "2018-07-30", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 5, "location_summary": "Long Beach, California • Shreveport, Louisiana • Newark, New Jersey + 2 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Newark", "state": "New Jersey" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Chattanooga", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03497234" }, { "nct_id": "NCT03647449", "title": "Examining the Effects of Juice Fasting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Epigenetics", "Microbiome" ], "interventions": [ { "name": "Juice", "type": "DIETARY_SUPPLEMENT" }, { "name": "Caloric restriction via Plant-based meals", "type": "BEHAVIORAL" }, { "name": "Plant-based meal", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 24, "start_date": "2018-07-10", "completion_date": "2019-12-31", "has_results": false, "last_update_posted_date": "2020-02-27", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03647449" }, { "nct_id": "NCT03810664", "title": "A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Male Volunteers" ], "interventions": [ { "name": "Somatrogon", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OPKO Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 49, "start_date": "2019-01-18", "completion_date": "2019-04-19", "has_results": false, "last_update_posted_date": "2020-04-28", "last_synced_at": "2026-11-15T14:57:25.519Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03810664" } ] }